Developments and perspectives in radioablative techniques;Entwicklungen und perspektiven radioablativer verfahren

Radiologe

Volumn 47, Issue 12, 2007, Pages 1083-1088

  Jakobs, T F ^a   Hoffmann, R T ^a   Tatsch, K ^a   Trumm, C ^a   Reiser, M F ^a   Helmberger, T K ^b  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b KLINIKUM BOGENHAUSEN   (Germany)

Author keywords

90Yttrium; Colorectal cancer; Hepatocellular carcinoma; Metastatic breast cancer; Neuroendocrine tumor; Radioembolization; Trials

Indexed keywords

FLUOROURACIL; FOLINIC ACID; IRINOTECAN; OXALIPLATIN; RADIOSENSITIZING AGENT; YTTRIUM 90;

ARTIFICIAL EMBOLISM; BREAST CANCER; CHEMOEMBOLIZATION; COLORECTAL CANCER; COMPARATIVE STUDY; DOSIMETRY; HUMAN; LIVER CELL CARCINOMA; LIVER METASTASIS; NEUROENDOCRINE TUMOR; RADIOABLATIVE TECHNIQUE; RADIOEMBOLIZATION THERAPY; REVIEW; SURGICAL TECHNIQUE;

ANTINEOPLASTIC AGENTS; BRACHYTHERAPY; BREAST NEOPLASMS; CARCINOMA, HEPATOCELLULAR; CARCINOMA, NEUROENDOCRINE; CHEMOEMBOLIZATION, THERAPEUTIC; COLORECTAL NEOPLASMS; COMBINED MODALITY THERAPY; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MICROSPHERES; NEOPLASMS; RADIATION-SENSITIZING AGENTS; RADIOLOGY, INTERVENTIONAL; RANDOMIZED CONTROLLED TRIALS AS TOPIC; YTTRIUM RADIOISOTOPES;

EID: 36849017407     PISSN: 0033832X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00117-007-1572-y     Document Type: Review

References (41)

1. Bangash AK, Atassi B, Kaklamani V et al. (2007) 90Y radioembolization of metastatic breast cancer to the liver: toxicity, imaging response, survival. J Vasc Interv Radiol 18: 621-628
2. Bruix J, Llovet JM, Castells A et al. (1998) Transarterial embolization versus symptomatic treatment in patients with advanced hepatocellular carcinoma: results of a randomized, controlled trial in a single institution. Hepatology 27: 1578-1583
3. Bruix J, Sherman M (2005) Management of hepatocellular carcinoma. Hepatology 42: 1208-1236
4. Coldwell D, Nutting C, Kennedy AK (2005) Use of yttrium-90 SirSpheres to treat metastatic unresectable neuroendocrine tumors to the liver. World Congress of Gastrointestinal Cancer, June 27-30, Barcelona, Spain
5. Coldwell DM, Kennedy AS, Nutting CW (2007) Use of Yttrium-90 microspheres in the treatment of unresectable hepatic metastases from breast cancer. Int J Radiat Oncol Biol Phys 59(3): 800-804
6. Gramont A de, Figer A, Seymour M et al. (2000) Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer. J Clin Oncol 18: 2938-2947
7. Douillard JY, Cunningham D, Roth AD et al. (2000) Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial. Lancet 355: 1041-1047
8. Emmanouilides C, Sfakiotaki G, Androulakis N et al. (2007) Front-line bevacizumab in combination with oxaliplatin, leucovorin and 5-fluorouracil (FOLFOX) in patients with metastatic colorectal cancer: a multicenter phase II study. BMC Cancer 7: 91
9. Geschwind JF, Salem R, Carr BI et al. (2004) Yttrium-90 microspheres for the treatment of hepatocellular carcinoma. Gastroenterology 127: 194-205
10. Giantonio BJ, Catalano PJ, Meropol NJ et al. (2007) Bevacizumab in combination with oxaliplatin, fluorouracil, and leucovorin (FOLFOX4) for previously treated metastatic colorectal cancer: results from the Eastern Cooperative Oncology Group Study E3200. J Clin Oncol 25: 1539-1544
11. Goldstein D, van Hazel G, Pavlakis N et al. (2005) Selective internal radiation therapy (SIRT) plus systemic chemotherapy with irinotecan: a phase I dose escalation study. American Society of Clinical Oncology Annual Meeting, May 13-17, Orlando, Fl
12. Ho S, Lau JW, Leung TW (2001) Intrahepatic (90)Y-microspheres for hepatocellular carcinoma. J Nucl Med 42: 1587-1589
13. Jakobs TF, Hoffman RT, Dehm K et al. (2007) Regional 90Yttrium micropshere treatment of chemorefractory colorectal cancer liver metastases. Submitted
14. Jakobs TF, Hoffmann RT, Fischer T et al. (2007) Radioembolization in patients with breast cancer hepatic metastases. Submitted
15. Jakobs TF, Hoffmann RT, Poepperl G et al. (2007) Mid-term results in otherwise treatment refractory primary or secondary liver confined tumours treated with selective internal radiation therapy (SIRT) using (90)Yttrium resin-microspheres. Eur Radiol 17: 1320-1330
16. Kennedy A, Nag S, Salem R et al. (2007) Recommendations for radioembolization of hepatic malignancies using yttrium-90 microsphere brachytherapy: a consensus panel report from the radioembolization brachytherapy oncology consortium. Int J Radiat Oncol Biol Phys 68: 13-23
17. Kennedy AS, Coldwell D, Nutting C et al. (2005) Hepatic brachytherapy for GI neuroendocrine tumors with Y90 microspheres: long-term USA results. International Congress on Anti-Cancer Treatment, February 1-4, Paris, France
18. Kennedy AS, Coldwell D, Nutting C et al. (2006) Resin 90Y-microsphere brachytherapy for unresectable colorectal liver metastases: modern USA experience. Int J Radiat Oncol Biol Phys 65: 412-425
19. Kennedy AS, McNeillie P et al. (2006) Fractionation, dose selection, and response of hepatic metastases of neuroendocrine tumors after Y90 microsphere brachytherapy. Annual Meeting of the American Brachytherapy Society, May 10-12, Philadelphia
20. Kennedy AS, Nutting C, Coldwell D et al. (2004) Pathologic response and microdosimetry of (90)Y microspheres in man: review of four explanted whole livers. Int J Radiat Oncol Biol Phys 60: 1552-1563
21. King J, Morris DL, Glenn D et al. (2006) Pilot study of SIR-Spheres in liver metastases from neuroendocrine cancer (NETLM). Third European Neuroendocrine Tumor Society (ENTS) Conference, Prague, Czech Republic
22. Kulik LM, Atassi B, van Holsbeeck L et al. (2006) Yttrium-90 microspheres (TheraSphere) treatment of unresectable hepatocellular carcinoma: downstaging to resection, RFA and bridge to transplantation. J Surg Oncol 94: 572-586
23. Lau WY, Ho S, Leung TW et al. (1998) Selective internal radiation therapy for nonresectable hepatocellular carcinoma with intraarterial infusion of 90yttrium microspheres. Int J Radiat Oncol Biol Phys 40: 583-592
24. Lau WY, Leung WT, Ho S et al. (1994) Treatment of inoperable hepatocellular carcinoma with intrahepatic arterial yttrium-90 microspheres: a phase I and II study. Br J Cancer 70: 994-999
25. Llovet JM, Burroughs A, Bruix J (2003) Hepatocellular carcinoma. Lancet 362: 1907-1917
26. Llovet JM, Fuster J, Bruix J (1999) Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation. Hepatology 30: 1434-1440
27. Llovet JM, Real MI, Montana X et al. (2002) Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial. Lancet 359: 1734-1739
28. Mazzaferro V, Regalia E, Doci R et al. (1996) Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 334: 693-699
29. Miller KD, Sledge GW jr (1999) The role of chemotherapy for metastatic breast cancer. Hematol Oncol Clin North Am 13: 415-434
30. Rhee TK, Omary RA, Gates V et al. (2005) The effect of catheter-directed CT angiography on yttrium-90 radioembolization treatment of hepatocellular carcinoma. J Vasc Interv Radiol 16: 1085-1091
31. Salem R, Lewandowski R, Roberts C et al. (2004) Use of Yttrium-90 glass microspheres (TheraSphere) for the treatment of unresectable hepatocellular carcinoma in patients with portal vein thrombosis. J Vasc Interv Radiol 15: 335-345
32. Salem R, Lewandowski RJ, Atassi B et al. (2005) Treatment of unresectable hepatocellular carcinoma with use of 90Y microspheres (TheraSphere): safety, tumor response, and survival. J Vasc Interv Radiol 16: 1627-1639
33. Sangro B, Bilbao JI, Boan J et al. (2006) Radioembolization using 90Y-resin microspheres for patients with advanced hepatocellular carcinoma. Int J Radiat Oncol Biol Phys 66: 792-800
34. Seiwert TY, Salama JK, Vokes EE (2007) The concurrent chemoradiation paradigm - general principles. Nat Clin Pract Oncol 4: 86-100
35. Sharma RA, Van Hazel GA, Morgan B et al. (2007) Radioembolization of liver metastases from colorectal cancer using yttrium-90 microspheres with concomitant systemic oxaliplatin, fluorouracil, and leucovorin chemotherapy. J Clin Oncol 25: 1099-1106
36. Sojan S, Bartholomeusz D (2005) Cutaneous radiation necrosis as a complication of yttrium-90 synovectomy. Hell J Nucl Med 8: 58-59
37. Stathopoulos GP, Rigatos SK, Stathopoulos JG et al. (2005) Efficacy and tolerability of oxaliplatin plus irinotecan 5-fluouracil and leucovorin regimen in advanced stage colorectal cancer patients pretreated with irinotecan 5-fluouracil and leucovorin. Am J Clin Oncol 28: 565-569
38. Stockler M, Wilcken NR, Ghersi D, Simes RJ (2000) Systematic reviews of chemotherapy and endocrine therapy in metastatic breast cancer. Cancer Treat Rev 26: 151-168
39. Stubbs RS, O'Brien I, Correia MM (2006) Selective internal radiation therapy with 90Y microspheres for colorectal liver metastases: single-centre experience with 100 patients. ANZ J Surg 76: 696-703
40. Tournigand C, Andre T, Achille E et al. (2004) FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study. J Clin Oncol 22: 229-237
41. Voboril R (2005) Blood supply of metastatic liver tumors: an experimental study. Int Surg 90: 71-77